Trials / Conditions / Stage III Thyroid Gland Medullary Carcinoma AJCC v7
Stage III Thyroid Gland Medullary Carcinoma AJCC v7
3 registered clinical trials studyying Stage III Thyroid Gland Medullary Carcinoma AJCC v7.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Completed | Pazopanib Hydrochloride in Treating Patients With Advanced Thyroid Cancer NCT00625846 | National Cancer Institute (NCI) | Phase 2 |
| Completed | Sorafenib Tosylate in Treating Patients With Metastatic, Locally Advanced, or Recurrent Medullary Thyroid Canc NCT00390325 | National Cancer Institute (NCI) | Phase 2 |
| Completed | Sunitinib Malate in Treating Patients With Thyroid Cancer That Did Not Respond to Iodine I 131 and Cannot Be R NCT00381641 | National Cancer Institute (NCI) | Phase 2 |